Chief Innovation Officer
Short Separator
Maravai LifeSciences
Dr. Kate Broderick has more than 15 years of
experience in the life science industry. A
recognized vaccine expert, Dr. Broderick has a broad background in device and product
development in the DNA therapeutic and drug delivery field. Prior to joining Maravai in 2022, Dr. Broderick held roles of increasing responsibility at Inovio Pharmaceuticals, most recently as Senior Vice President, R&D. Dr. Broderick has served as a principal investigator for a variety of grants and awards from government agencies and non-profits, including the National Institutes of Health. She received her PhD from the University of Glasgow in Scotland and completed her post-doctoral research at the University of California, San Diego.